Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03562481 · ClinicalTrials.gov registry record · Phase 4

Clinical Trial Comparing Effectiveness of Buffered Versus Unbuffered Local Anesthetic in Children Ages 10-12 Years

A Phase 4 study of Pain and Anesthesia, Local, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
Phase 4
Development phase
26
Enrollment target
1
Study location

NCT03562481: Completed Phase 4 study of Pain and Anesthesia, Local, sponsored by University of North Carolina, Chapel Hill.

NCT03562481 is a Phase 4 study of Pain and Anesthesia, Local that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 26 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03562481, a Phase 4 study of Pain and Anesthesia, Local, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
Phase 4
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

Local anesthesia is an integral part of clinical pediatric dental practice, but it has challenges. It can be uncomfortable for children, and the risk of adverse events limits how much is used. Some evidence suggests benefits of buffering local anesthetics including equal effect with less pain on injection. These findings have not been replicated and validated among pediatric populations, creating a gap in the knowledge base. To address this knowledge gap and contribute to the evidence base on safety and efficacy of local anesthesia in pediatric dentistry, this investigation proposes to compare the anesthetic effects of buffered 1% lidocaine with those of unbuffered 2%, among children. The specific aims of this investigation are to determine differences between buffered 1% and unbuffered 2% lidocaine (both with 1:100,000 epinephrine) used for inferior alveolar nerve block (IAN) anesthesia, in the following domains: 1. Pain experience on injection, time to onset following the administration, and time to recovery \[subjective\] 2. Blood lidocaine levels 15 minutes following the administration and duration of pulpal anesthesia \[objective\] Null Hypotheses: 1. No difference exists in anesthetic effectiveness for pulpal anesthesia after intraoral IAN block between buffered 1% Lidocaine with 1:100,000 epinephrine as compared to unbuffered 2% Lidocaine with 1:100,000 epinephrine. 2. No differences exist in peak blood lidocaine levels, pain on injection, time to lip numbness, and duration of anesthesia between the two drug formulations. Randomized subjects will be injected orally for bottom jaw anesthesia, with 3cc of buffered 1% lidocaine (30mg) 1:100,000 epinephrine or 3cc unbuffered of 2% lidocaine (60mg) 1:100,000 epinephrine. The injectable volume of the buffered formulation will include 0.3cc of 8.4% sodium bicarbonate. One faculty member in the Department of Pediatric Dentistry at the University of North Carolina (UNC) School of Dentistry will administer the dr

Primary Outcome

Perceived pain on injection, self-reported verbally using a Likert scale from 1-10, with lower numbers corresponding to less pain (1 = "no pain," 10 = "worst pain imaginable"). Lower scores reflect a lesser degree of pain.

Conditions Studied

Interventions

  • DRUG 1% Buffered Lidocaine 1:100,000 Epinephrine
  • DRUG 2% Unbuffered Lidocaine 1:100,000 Epinephrine

Study Locations (1)

North Carolina

  • UNC School of Dentistry - Chapel Hill

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2018-07-24
Est. Completion 2019-06-30
Phase Phase 4

What the finished NCT03562481 record still lists

NCT03562481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (91% lower).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which 1% Buffered Lidocaine 1:100,000 Epinephrine is the first listed.

NCT03562481 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03562481 about?

NCT03562481 is a clinical study titled "Clinical Trial Comparing Effectiveness of Buffered Versus Unbuffered Local Anesthetic in Children Ages 10-12 Years". Local anesthesia is an integral part of clinical pediatric dental practice, but it has challenges. It can be uncomfortable for children, and the risk of adverse events limits how much is used. Some evidence suggests benefits of buffering local anesthetics including equal effect with less pain on inj...

What is the current status of trial NCT03562481?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2018-07-24. Estimated completion is 2019-06-30.

What conditions does trial NCT03562481 study?

This clinical trial studies the following conditions: Pain, Anesthesia, Local.

What interventions are being tested in trial NCT03562481?

The interventions under investigation include: 1% Buffered Lidocaine 1:100,000 Epinephrine (DRUG), 2% Unbuffered Lidocaine 1:100,000 Epinephrine (DRUG).

Who is sponsoring clinical trial NCT03562481?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03562481 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03562481's enrollment target sits among peer trials

26 318th of 374 higher than 55 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03562481, the US trial registry maintained by the National Library of Medicine. NCT03562481 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.